Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 13 hours ago
NIH joins Trump’s $5B AI mission with biomedical research push
about 13 hours ago
The U.S. Department of Health and Human Services announced new efforts Wednesday...
Celldex ends skin disease program after failing phase 2 test
about 17 hours ago
A phase 2 study of Celldex’s barzolvolimab in a chronic skin disease...
House passes bill directing FDA to update animal testing rules
about 18 hours ago
The U.S. House of Representatives passed the FDA Modernization Act 3.0 this...
Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drug
about 19 hours ago
Royalty Pharma has secured a stake in another transthyretin-mediated amyloidosis drug, this...
Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challenge
about 19 hours ago
A group of 61 biopharma companies, executives and investors has filed an...
Crystalys mines $130M series B to push gout drug through phase 3
about 21 hours ago
Crystalys Therapeutics has raised $130 million in series B financing to advance...
‘We’re moving quickly’: Startup bags rare disease drug as Thiel-backed CEO eyes $50M fundraise
1 day ago
A rare disease startup with a mission to repurpose proven drugs has...
Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal
1 day ago
For years, as Big Pharma poured billions into ADCs, Novartis CEO Vas...
Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial role
1 day ago
Dan Malarek is leaving his role as chief executive of Roche’s sequencing...
Jupiter enters psychedelics space with $100M deal for PharmAla's MDMA drug
2 days ago
Jupiter Neurosciences will pay $3.3 million upfront to Canada's PharmAla Biotech for...
Agios says adios to sickle cell program over lackluster phase 2 data
2 days ago
A phase 2 study of Agios Pharmaceuticals’ next-generation pyruvate kinase activator has...
Indian generics maker Lupin seeds US spinout Kaveri with cash, clinical-phase cancer assets
2 days ago
Lupin has spun out two clinical-phase cancer drug candidates to create Kaveri...